Moderate

Chronic hepatic encephalopathy — secondary prophylaxis

Chronic HE · Gastroenterology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

After an episode of overt hepatic encephalopathy in cirrhosis, long-term therapy with lactulose and rifaximin reduces recurrence; management also addresses precipitants, nutrition and transplant candidacy.

Red flags

  • Rapidly deepening encephalopathy / reduced GCS (airway risk)
  • GI bleeding as precipitant
  • Sepsis or SBP
  • Focal neurology (exclude intracranial cause)

Assessment

Differential diagnosis

  • Other causes of confusion (sepsis, metabolic, intracranial)
  • Covert/minimal HE
  • Drug/alcohol intoxication or withdrawal
  • Hyponatraemia
  • Wernicke's encephalopathy

Investigations

  • Clinical grading (West Haven); exclude other causes of encephalopathy
  • U&E, glucose, ammonia (supportive, not diagnostic), septic screen
  • Review precipitants: constipation, infection, GI bleed, dehydration, sedatives
  • Liver function and MELD/Child-Pugh
  • Imaging (CT head) if focal signs or diagnostic doubt

Management

  • Confirm the index episode was overt HE and reversible precipitants were treated
  • Identify and correct ongoing precipitants: constipation, infection, GI bleeding, diuretic overuse, sedatives
  • Start lactulose titrated to 2–3 soft stools per day as foundation therapy
  • Add rifaximin for secondary prophylaxis after a first/recurrent episode of overt HE
  • Maintain adequate protein intake — do NOT protein-restrict; aim for high protein/calorie nutrition
  • Treat constipation promptly and educate patient/carers on early signs of relapse
  • Review and minimise sedating medications
  • Manage hyponatraemia and avoid aggressive diuresis
  • Consider TIPS reduction/occlusion if HE is TIPS-related and refractory
  • Refer for liver transplant assessment in recurrent/refractory HE
  • Arrange driving and safety counselling and regular follow-up

Drugs & doses

Lactulose 20–30 mL PO 2–3 times daily (titrate to 2–3 soft stools/day)
Rifaximin 550 mg PO twice daily (secondary prophylaxis)
Phosphate enema PR if unable to take oral lactulose acutely

Disposition

Outpatient hepatology with carer education; transplant referral for recurrent/refractory disease.

Complications & pitfalls

  • Recurrent hospital admissions
  • Aspiration and airway compromise in severe episodes
  • Malnutrition and sarcopenia (worsen HE)
  • Reduced quality of life and loss of independence

Exam pearls

  • Do not restrict protein — malnutrition and sarcopenia worsen encephalopathy; aim for high protein/calorie intake
  • Rifaximin added to lactulose markedly reduces recurrence of overt HE
  • Always hunt for and treat a precipitant (constipation, infection, bleed) at each episode
  • Minimal/covert HE affects driving and quality of life even without obvious confusion

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.